Skip to content
MMR Sign In Subscribe

Camber expands cardiovascular portfolio with Tribenzor generic

Camber Pharmaceuticals launched Olmesartan medoxomil, Amlodipine, and Hydrochlorothiazide Tablets, a generic of Tribenzor, expanding its hypertension treatment options.

,   and  Thorvardur de Shong
2 min read

PISCATAWAY, N.J. — Camber Pharmaceuticals has expanded its cardiovascular portfolio by launching Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets, a generic version of Tribenzor indicated for the treatment of hypertension.

According to the Centers for Disease Control and Prevention, about 40% to 45% of U.S. adults have hypertension, underscoring the ongoing demand for accessible treatment options.

Camber’s new product is available in 30-count and 90-count bottles in the following strengths:

  • 20 mg/5 mg/12.5 mg
  • 40 mg/5 mg/12.5 mg
  • 40 mg/5 mg/25 mg
  • 40 mg/10 mg/12.5 mg
  • 40 mg/10 mg/25 mg

The launch adds to Camber’s growing portfolio of generic medications, providing health care providers and pharmacies with additional treatment options across a range of therapeutic categories.

Click to learn more

Submit Your Press Release

Have news to share? Send us your press releases and announcements.

Send Press Release

Latest

PCMA adds public affairs leaders
Pharmacy

PCMA adds public affairs leaders

The new hires strengthen the association’s advocacy, coalition-building, and stakeholder engagement capabilities at the state and federal levels. 

,   and  CDR